Approval · Notice of Compliance 18476 · 2016
PONSTAN: Notice of Compliance 18476
Issued September 13, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18476
- Date
- September 13, 2016
- Company
- Aspri Pharma Canada Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PONSTAN | 00155225 | Dormant |
Medicinal ingredients
- MEFENAMIC ACID 250 MG per CAP